Ourania Tatsis, EVP, Chief Reg. & Quality Officer at VERTEX PHARMACEUTICALS INC / MA (VRTX), sold 4,018 shares at $480.95 ($1.9M) on 2025-02-25, disclosed to the SEC on 2025-02-26.
Scheduled sale ($1.9M) by EVP, Chief Reg. & Quality Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $483.28 | 3,310 | $1.6M | 82.4% |
| 2 | $480.95 | 354 | $170K | 8.8% |
| 3 | $480.95 | 354 | $170K | 8.8% |
| Total | $482.87 avg | 4,018 | $1.9M | 100% |
| Filing → |
| VRTX | SELL | 2026-02-19 | $472K | — | Filing → |
| VRTX | SELL | 2026-02-18 | $750K | — | Filing → |
| VRTX | SELL | 2026-02-12 | $215K | — | Filing → |